We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$16.4B
AUM Growth
+$1.76B
Cap. Flow
+$963M
Cap. Flow %
5.86%
Top 10 Hldgs %
36.55%
Holding
2,213
New
752
Increased
404
Reduced
406
Closed
645

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$276M
2
AAPL icon
Apple
AAPL
+$180M
3
DUK icon
Duke Energy
DUK
+$75.7M
4
COP icon
ConocoPhillips
COP
+$73.6M
5
AVGO icon
Broadcom
AVGO
+$70.4M

Sector Composition

Rank Sector Weight
1 Healthcare 11.11%
2 Technology 9.83%
3 Utilities 6.25%
4 Real Estate 4.8%
5 Consumer Discretionary 4.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGEE icon
1901
MGE Energy Inc
MGEE
$2.97B
-7,333
Closed -$548K
MIDD icon
1902
Middleby
MIDD
$5.22B
-3,937
Closed -$483K
MIRM icon
1903
Mirum Pharmaceuticals
MIRM
$5.87B
-43,747
Closed -$1.5M
MLYS icon
1904
Mineralys Therapeutics
MLYS
$2.27B
-274,316
Closed -$3.21M
MNDY icon
1905
monday.com
MNDY
$3.84B
-18,912
Closed -$4.55M
MNTK icon
1906
Montauk Renewables
MNTK
$268M
-35,179
Closed -$201K
MO icon
1907
Altria Group
MO
$110B
-23,697
Closed -$1.08M
MOD icon
1908
Modine Manufacturing
MOD
$10.5B
-20,262
Closed -$2.03M
CALY
1909
Callaway Golf Company
CALY
$2.84B
-258,641
Closed -$3.96M
MOH icon
1910
Molina Healthcare
MOH
$10.5B
-4,035
Closed -$1.2M
MORN icon
1911
Morningstar
MORN
$8.1B
-2,410
Closed -$713K
MPC icon
1912
Marathon Petroleum
MPC
$101B
-347,995
Closed -$60.4M
MRK icon
1913
Merck
MRK
$376B
-298,569
Closed -$37M
MRNA icon
1914
CALL
Moderna
MRNA
$57.9B
-30,800
Closed -$3.66M
MRNA icon
1915
PUT
Moderna
MRNA
$57.9B
-24,400
Closed -$2.9M
MRSN
1916
DELISTED
Mersana Therapeutics
MRSN
-4,287
Closed -$215K
MRVL icon
1917
CALL
Marvell Technology
MRVL
$213B
-131,200
Closed -$9.17M
MS icon
1918
Morgan Stanley
MS
$336B
-155,144
Closed -$15.6M
MSBI icon
1919
Midland States Bancorp
MSBI
$682M
-14,964
Closed -$339K
MSEX icon
1920
Middlesex Water
MSEX
$1.1B
-5,108
Closed -$267K
MSTR icon
1921
Strategy Inc
MSTR
$47.4B
-59,800
Closed -$8.55M
MT icon
1922
ArcelorMittal
MT
$54.4B
-534,462
Closed -$12.3M
MTD icon
1923
Mettler-Toledo International
MTD
$28B
-10,155
Closed -$14.2M
MTB icon
1924
M&T Bank
MTB
$34.7B
-15,517
Closed -$2.57M
MTRN icon
1925
Materion
MTRN
$4.83B
-3,664
Closed -$396K

Similar funds

Michael Gelband's Q3 2024 Portfolio in Review

As of Q3 2024, Michael Gelband held 2,213 positions worth $16.4B, up 12% from $14.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Michael Gelband deployed $963M of net new capital in Q3 2024, opening 752 new positions and adding to 404 existing holdings. Its largest new stake was Mondelez International: 1,784,906 shares worth $131M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 10% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was ConocoPhillips, an estimated $73.6M trimmed.

  • Michael Gelband's largest Q3 2024 buy was Mondelez International: 1,784,906 shares worth $131M.
  • Michael Gelband added most to Microsoft in Q3 2024, an estimated $384M increase.
  • Michael Gelband's biggest Q3 2024 reduction was ConocoPhillips, cutting an estimated $73.6M.
  • Michael Gelband fully exited Amazon in Q3 2024, selling an estimated $276M.
  • Michael Gelband's ten largest holdings make up 37% of its $16.4B portfolio in Q3 2024.
  • Michael Gelband opened 752 new positions and closed 645 in Q3 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $16.4B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.